One of the key challenges in developing effective,
targeted cancer treatments is the heterogeneity of the cancer cells
themselves. This variation makes it difficult for the immune system
to recognize, respond to and actively fight against tumors. Now,
however, new advances in nanotechnology are making it possible to
deliver targeted, personalized “vaccines” to treat
cancer.